Literature DB >> 29892175

Outcome of Living Donor Liver Transplantation for Wilson's Disease in Adults: A Single Center Experience.

Narendra S Choudhary1, Sanjiv Saigal1, Neeraj Saraf1, Amit Rastogi1, Sanjay Goja1, Prashant Bhangui1, Srinivasan Thiagrajan1, Dheeraj Gautam2, Deepak Govil3, Vijay Vohra4, Arvinder S Soin1.   

Abstract

INTRODUCTION: Although liver transplantation is a definitive cure for Wilson's disease (WD), there is limited data about results of living donor liver transplantation (LDLT) in adults.
MATERIAL AND METHODS: 18 adults underwent LDLT for WD. The presentations before LDLT were decompensated cirrhosis (n = 16), acute on chronic liver failure (n = 1) and acute liver failure (n = 1). The donors were parents (n = 2), siblings (n = 3), cousin (n = 1), daughter (n = 1), nephew (n = 1), spouse or relatives of spouse (n = 9) and from swap transplantation (n = 1). All genetically related donors were negative for screening of WD.
RESULTS: The study cohort comprised of 15 males and 3 females, aged 32 ± 10 years. Severity of liver disease (excluding acute liver failure patient) was as follows; Child's score 10 ± 2, model for end-stage liver disease (MELD) score 18 ± 6. The graft to recipient weight ratio was 1 ± 0.2. The ICU and hospital stay were 5.5 ± 0.9 and 15 ± 5 days. Two patients died in first month after liver transplantation, rest of patients are doing well at median 15 (8-38 months). Two patients had acute cellular rejection that responded to steroids, one had hepatic artery thrombosis and 2 had biliary strictures. Three patients had neurological symptoms; 2 of these patients had partial recovery while one had complete recovery. There was no significant difference between LDLT from genetically related or unrelated donors.
CONCLUSION: LDLT for WD in adults is associated with good outcomes.

Entities:  

Keywords:  LDLT, living donor liver transplantation; MELD, model for end-stage liver disease; WD, Wilson's disease; Wilson's disease; complications; living donor liver transplantation; survival

Year:  2017        PMID: 29892175      PMCID: PMC5992308          DOI: 10.1016/j.jceh.2017.11.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  15 in total

1.  Diagnosis and treatment of Wilson disease: an update.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

2.  Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure.

Authors:  D H Berman; R I Leventhal; J S Gavaler; E M Cadoff; D H Van Thiel
Journal:  Gastroenterology       Date:  1991-04       Impact factor: 22.682

Review 3.  Wilson disease: pathogenesis and clinical considerations in diagnosis and treatment.

Authors:  Richard Rosencrantz; Michael Schilsky
Journal:  Semin Liver Dis       Date:  2011-09-07       Impact factor: 6.115

4.  Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients.

Authors:  Chloé Laurencin; Anne Sophie Brunet; Jérôme Dumortier; Laurence Lion-Francois; Stéphane Thobois; Jean Yves Mabrut; Rémi Dubois; France Woimant; Aurélia Poujois; Olivier Guillaud; Alain Lachaux; Emmanuel Broussolle
Journal:  Eur Neurol       Date:  2016-11-19       Impact factor: 1.710

5.  Influence of Liver Transplantation on Neuropsychiatric Manifestations of Wilson Disease.

Authors:  M A Yagci; A Tardu; S Karagul; I Ertugrul; V Ince; S Kirmizi; B Unal; B Isik; C Kayaalp; S Yilmaz
Journal:  Transplant Proc       Date:  2015-06       Impact factor: 1.066

6.  Living-related liver transplantation for Wilson's disease.

Authors:  Xue-hao Wang; Feng Cheng; Feng Zhang; Xiang C Li; Lian B Kong; Guo Q Li; Jun Li; Xiao F Qian
Journal:  Transpl Int       Date:  2005-06       Impact factor: 3.782

7.  Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults.

Authors:  Ronen Arnon; Rachel Annunziato; Michael Schilsky; Tamir Miloh; Asha Willis; Mark Sturdevant; Arnond Sakworawich; Frederick Suchy; Nanda Kerkar
Journal:  Clin Transplant       Date:  2010-10-14       Impact factor: 2.863

8.  Outcomes of living-related liver transplantation for Wilson's disease: a single-center experience in China.

Authors:  Feng Cheng; Guo-Qiang Li; Feng Zhang; Xiang-cheng Li; Bei-cheng Sun; Lian-bao Kong; Li-yong Pu; Ke Wang; Xiao-feng Qian; Wei You; Xue-hao Wang
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

Review 9.  Diagnosis and phenotypic classification of Wilson disease.

Authors:  Peter Ferenci; Karel Caca; Georgios Loudianos; Georgina Mieli-Vergani; Stuart Tanner; Irmin Sternlieb; Michael Schilsky; Diane Cox; Frieder Berr
Journal:  Liver Int       Date:  2003-06       Impact factor: 5.828

10.  Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran.

Authors:  Kamran B Lankarani; Seyed Ali Malek-Hosseini; Saman Nikeghbalian; Mohsen Dehghani; Mohammad Pourhashemi; Kourosh Kazemi; Parisa Janghorban; Maryam Akbari; Sulmaz Ghahramani; Bijan Eghtesad; Maryam Moini; Abbas Rahmi Jaberi; Alireza Shamsaifar; Siavosh Gholami; Fatemeh Rahmanian; Bita Geramizadeh
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

View more
  4 in total

1.  Wilson's Disease Update: An Indian Perspective.

Authors:  Niraj Kumar; L K Prashant; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2021-10-14       Impact factor: 1.383

2.  The advantage of early liver transplantation for Wilson's disease using living donors.

Authors:  Mehmet Burak Dal; Altan Alim; Koray Acarli
Journal:  Prz Gastroenterol       Date:  2021-09-17

3.  Liver transplantation as a treatment for Wilson's disease with neurological presentation: a systematic literature review.

Authors:  Tomasz Litwin; Jan Bembenek; Agnieszka Antos; Adam Przybyłkowski; Marta Skowrońska; Iwona Kurkowska-Jastrzębska; Anna Członkowska
Journal:  Acta Neurol Belg       Date:  2022-01-26       Impact factor: 2.396

4.  Wilson's Disease Update: An Indian Perspective.

Authors:  Kalyan Bhattacharya; Bindu Thankappan
Journal:  Ann Indian Acad Neurol       Date:  2022-02-18       Impact factor: 1.383

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.